Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Monetary Wellness: Planning Tips for Independence from the rat race- Vote in favor of your Number one method for praising a birthday
- Knesset sets special panel to fast-track Karhi’s communications reform
- Kennedy approves adding two rare disorders to newborn screenings
- Vote in favor of Your Fantasy Vehicle: Which Notable Model Catches Your Heart?
- Grass Care Administrations for a Wonderful, Sound Yard
- From Dread to Certainty: Individual Accounts of Strengthening
- The Specialty of Compromise: Examples from Reality
- Manageable Living: Eco-Accommodating Decisions for Regular day to day existence
